Form CORRESP - Correspondence:
SEC Accession No. 0001193125-24-104917
Filing Date
2024-04-22
Accepted
2024-04-22 16:29:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 6163
  Complete submission text file 0001193125-24-104917.txt   7317
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)